APLS icon

Apellis Pharmaceuticals
APLS

Overview Fund Activity

254 hedge funds and large institutions have $4.34B invested in Apellis Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 126 increasing their positions, 64 reducing their positions, and 106 closing their positions.

Holders
254
Holders Change
-62
Holders Change %
-19.62%
% of All Funds
4.05%
Holding in Top 10
10
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-33.33%
% of All Funds
0.16%
New
46
Increased
126
Reduced
64
Closed
106
Calls
$373M
Puts
$139M
Net Calls
+$235M
Net Calls Change
+$171M

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$577M
2
EC
2
EcoR1 Capital
California
$415M
3
SPC
3
Slate Path Capital
New York
$78.7M
4
Jennison Associates
4
Jennison Associates
New York
$135M
5
State Street
5
State Street
Massachusetts
$123M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$67.8M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$0
3
Lord, Abbett & Co
3
Lord, Abbett & Co
New Jersey
$0
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$86M
5
PA
5
Perceptive Advisors
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Wellington Management Group
1
Wellington Management Group
Massachusetts
$577M 15,167,044 +8,502,769 +128%
ACA
2
Avoro Capital Advisors
New York
$423M 11,111,111 – –
EC
3
EcoR1 Capital
California
$415M 10,899,859 +5,448,212 +100%
Vanguard Group
4
Vanguard Group
Pennsylvania
$360M 9,469,977 +68,687 +0.7%
T. Rowe Price Investment Management
5
T. Rowe Price Investment Management
Maryland
$248M 6,519,471 +880,596 +16%
BlackRock
6
BlackRock
New York
$201M 5,272,746 -474,881 -8%
Jennison Associates
7
Jennison Associates
New York
$135M 3,542,209 +1,571,606 +80%
State Street
8
State Street
Massachusetts
$123M 3,238,114 +955,029 +42%
OCA
9
Octagon Capital Advisors
New York
$119M 3,130,000 +511,700 +20%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$86M 2,259,766 -1,965,829 -47%
JPMorgan Chase & Co
11
JPMorgan Chase & Co
New York
$84.4M 2,217,747 +430,765 +24%
SPC
12
Slate Path Capital
New York
$78.7M 2,068,000 +2,068,000 New
CAM
13
Cormorant Asset Management
Massachusetts
$76.1M 2,000,000 +690,000 +53%
T. Rowe Price Associates
14
T. Rowe Price Associates
Maryland
$67.8M 1,783,241 -5,288,985 -75%
BC
15
Boxer Capital
California
$65.7M 1,726,000 +150,000 +10%
AG
16
Artal Group
Luxembourg
$63.3M 1,664,572 +614,505 +59%
Morgan Stanley
17
Morgan Stanley
New York
$61.2M 1,608,996 +852,331 +113%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$59.2M 1,554,826 +56,437 +4%
O
19
OrbiMed
New York
$47.9M 1,260,500 +350,300 +38%
Macquarie Group
20
Macquarie Group
Australia
$41M 1,076,548 +301,068 +39%
PCH
21
Polar Capital Holdings
United Kingdom
$40.1M 1,053,875 +588,875 +127%
Norges Bank
22
Norges Bank
Norway
$40M 1,052,193 +29,167 +3%
Assenagon Asset Management
23
Assenagon Asset Management
Luxembourg
$38.9M 1,023,507 +524,797 +105%
Fiera Capital (Canada)
24
Fiera Capital (Canada)
Quebec, Canada
$35M 919,690 +391,770 +74%
ITP
25
Iron Triangle Partners
Connecticut
$33.5M 880,000 +880,000 New
1
2 3 4 5